Efficacy and safety of valganciclovir vs. oral ganciclovir for ... | 合法藥品大搜索

藥理作用 · Valganciclovir為具L-valyl ester基之ganciclovir前驅物，口服後經腸道及肝臟之酯水解酵素快速轉變為ganciclovir。 · 適應症 · 1.用於治療愛滋病患者罹患巨 ... Read More

在以 Valcyte®（和ganciclovir ）治療的病患中， 的病人） 曾觀察到有嚴重白血球減少 症 、嗜中性球減少症、貧血、血小板減少症、全血球減少症、骨髓抑制毒性 ... Read More

藥理作用. Valganciclovir為具L-valyl ester基之ganciclovir前驅物，口服後經腸道及肝臟之酯水解酵素快速轉變為ganciclovir。Ganciclovir 為2'-deoxyguanosine之 ... Read More

由 KC Zachary 著作 · 被引用 4 次 — Ganciclovir and valganciclovir are used primarily in treating cytomegalovirus (​CMV) infections. In vitro synergy with foscarnet has been observed ... Read More

Valganciclovir為具L-valyl ester基之ganciclovir前驅物，口服後經腸道及肝臟之酯水解酵素快速轉變為ganciclovir。Ganciclovir為2'-deoxyguanosine之合成類似 ... Read More

Valganciclovir 錠. 主成份. 商品名. 中文商品名. 含量. Valganciclovir HCl. Valcyte ... Valganciclovir 口服吸收後於體內水解成ganciclovir，動物實驗發現ganciclovir. Read More

由 C Paya 著作 · 2004 · 被引用 866 次 — Except for a higher incidence of neutropenia with valganciclovir (8.2%, vs 3.2% ganciclovir) the safety profile was similar for both drugs. Overall, once-daily oral ... Read More

Valcyte經代謝形成ganciclovir，其臨床毒性包括顆粒性球減少、貧血及血小板. 減少。動物試驗中，ganciclovir具有致癌性、致畸胎性並造成精子無法形成。 1. 說明. Read More

由 S Vaziri 著作 · 2014 · 被引用 14 次 — This study is aimed to compare the efficacy of ganciclovir (GCV) and valganciclovir (VGC) for prevention and treatment of infection with CMV. Materials and ... Read More

2021年1月15日 — Valganciclovir (VGCV) and ganciclovir (GCV) doses must be adjusted ... Keywords: valganciclovir, ganciclovir, serum levels, therapeutic drug ... Read More